Author:
Deuschl C.,Kirchner J.,Poeppel T. D.,Schaarschmidt B.,Kebir S.,El Hindy N.,Hense J.,Quick H. H.,Glas M.,Herrmann K.,Umutlu L.,Moenninghoff C.,Radbruch A.,Forsting M.,Schlamann M.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference45 articles.
1. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol : Off J Am Soc Clin Oncol. 2010;28:1963–72.
https://doi.org/10.1200/JCO.2009.26.3541
.
2. Radbruch A, Lutz K, Wiestler B, Baumer P, Heiland S, Wick W, et al. Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the response assessment in Neurooncology criteria. Neuro-Oncology. 2012;14:222–9.
https://doi.org/10.1093/neuonc/nor200
.
3. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol. 2005;26:1967–72.
4. Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neuro-Oncol. 2007;82:81–3.
https://doi.org/10.1007/s11060-006-9241-y
.
5. Sorensen AG, Batchelor TT, Wen PY, Zhang WT, Jain RK. Response criteria for glioma. Nat Clin Pract Oncol. 2008;5:634–44.
https://doi.org/10.1038/ncponc1204
.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献